B22956/1, a new intravascular contrast agent for MRI: first administration to humans--preliminary results.
Bracco Imaging S.p.A., Milan, Italy.
Anna
A
La Noce
S
S
Stoelben
K
K
Scheffler
J
J
Hennig
H Maier
HM
Lenz
R
R
La Ferla
V
V
Lorusso
F
F
Maggioni
F
F
Cavagna
D000328:Adult; D003287:Contrast Media / Q000008:administration & dosage* / Q000493:pharmacokinetics; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods*; D008297:Male; D009206:Myocardium; D009942:Organometallic Compounds / Q000008:administration & dosage* / Q000493:pharmacokinetics
C440468:B-22956-1; D003287:Contrast Media; D009942:Organometallic Compounds